BNIP3 and colon carcinoma: Cisplatin cytotoxicity increased with ascending BNIP3 level in several clonal variants of human colon carcinoma cell line HT29, and up‐regulation of BNIP3 in HT29 significantly increased its cisplatin sensitivity [30].